U.S. Online Retail and Ecommerce Stock News

NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

US Stock Market Today: S&P 500 Futures Rise as Shutdown Relief Lifts Sentiment

The Morning Bull - US Market Morning Update Monday, Nov, 10 2025 US stock futures are pointing modestly higher at the open, as investors weigh a breakthrough in Washington with the 10-year Treasury yield climbing to about 4.13%. The Senate moved closer to ending the government shutdown by agreeing to fund key agencies through late January. This offers some short-term stability, but not a complete solution, as negotiations on bigger issues like border security are still hanging over markets...
NasdaqGS:CNDT
NasdaqGS:CNDTProfessional Services

Conduent (CNDT) Is Down 24.6% After Cut to 2025 Revenue Outlook and Third-Quarter Losses

Conduent recently reported third-quarter 2025 results, noting a year-over-year revenue decline to US$767 million and shifting from net income last year to a net loss of US$46 million, alongside a lowered full-year revenue forecast. Despite this financial setback, Conduent highlighted operational improvements, new AI-powered product offerings, and board changes as part of its ongoing business transformation efforts. We'll examine how the reduced 2025 revenue guidance and profitability...
NYSE:NEU
NYSE:NEUChemicals

How NewMarket's (NEU) Dividend Increase Amid Weaker Earnings Has Changed Its Investment Story

NewMarket Corporation recently reported third-quarter 2025 results, with sales declining to US$690.31 million and net income at US$100.27 million, while simultaneously announcing a 9% increase in its quarterly dividend to US$3.00 per share. This decision to boost dividends despite lower earnings highlights management's ongoing confidence in the company’s financial strength and commitment to shareholder returns. We'll explore how NewMarket’s higher dividend payout, set against softer...
NasdaqCM:ELDN
NasdaqCM:ELDNBiotechs

Evaluating Eledon Pharmaceuticals (ELDN) Valuation Following Phase 2 BESTOW Results and Pipeline Progress

Eledon Pharmaceuticals (ELDN) is in the spotlight after presenting Phase 2 clinical trial results for its lead drug, tegoprubart, aimed at preventing rejection in kidney transplant patients. The data, while mixed on headline endpoints, has intensified market and medical sector curiosity about the company’s pipeline. See our latest analysis for Eledon Pharmaceuticals. Eledon’s share price took a dramatic hit this week, dropping nearly 50% in a single day after the Phase 2 trial update. This...
NYSE:SAH
NYSE:SAHSpecialty Retail

What Sonic Automotive (SAH)'s Federal Securities Probe After Q3 Earnings Drop Means For Shareholders

In the past week, Levi & Korsinsky began investigating Sonic Automotive for potential violations of federal securities laws following the company’s third-quarter 2025 financial results, which revealed a 33% decline in net income due to higher medical expenses and a larger effective income tax rate. The launch of a legal investigation after a sharp earnings drop has significant implications for investor confidence and Sonic Automotive’s risk profile. We'll explore how concerns over regulatory...